Jeffrey Kindler news from FiercePharma
News
Pfizer's Jeffrey Kindler - CEO Pay
Jeffrey Kindler - Pfizer Total Compensation: $12.6M 2007 Revenue: $48.6B2006 Revenue: $48.3BChange: .6% Details: 2007 was not Pfizer's best year, seeing that the company started things Read more...
Pharma CEOs mull industry "trust deficit'
We love it when pharma CEOs depart from their usual talking points about financial results and restructurings and pipelines, to wax philosophical on their place in the word. This week, we heard an Read more...
Woe is Pfizer, analysts say
Pfizer shares hit a 10-year low yesterday. And who can blame investors who sold, considering the Eeyore tone Wall Street analysts took after the drugmaker announced its Read more...
Wyeth, Pfizer chiefs see pay decline
Here's the latest installment in the exciting serial entitled "Pharma Paycheck, or Which Way But Up?" For recently retired Wyeth Read more...
Ex-Pfizerite indicted in off-label case
More evidence that the cover-up could be more lethal than the crime: A former Pfizer district sales manager has now been indicted for obstructing justice in connection with a 2004 off-label marketing Read more...
Analysts not impressed with Pfizer
Investors and analysts are none too impressed with Pfizer's new strategies as outlined by CEO Jeffrey Kindler and other execs during an annual Wall Street update yesterday. The stock fell to within Read more...
Is Pfizer's CEO as bold as promised?
Like natives encountering a strange explorer in an old B movie, investors hailed Jeffrey Kindler (photo) when he was Read more...
Pfizer vice chair says hasta la vista
He didn't win the horse race, so he's heading out for greener pastures. Pfizer Vice Chairman David Shedlarz will retire at year's end after a 31-year career there. Shedlarz stuck around for a year to Read more...
Pharma execs practice positive thinking
Throw a bunch of pharma execs into a room with financial analysts, and what do you get? Almost unmitigated hope. Thinking positive is a must when analysts are around, so as industry leaders stand up Read more...
Pfizer hires on the axe man
It's a tough job, but...well, you know the rest. Pfizer is bringing in financial fix-it guy Frank D'Amelio as its new CFO, and he'll have Read more...
Get more Jeffrey Kindler coverage at:
Paid Research Reports
- Drug Repositioning Strategies - Serendipity by design
- eHealthInsight Series: Online Patient Recruitment Strategies - Optimizing the clinical trial process
- Pricing & Reimbursement - Seven Major Markets Update
- Innovative Clinical Trial Design and Management: Trends, success stories and impact upon R&D budgets
- The Emerging Role of Postmarketing Clinical Research: Regulatory issues, strategic drivers and overall trends